ABT (Abbott Laboratories) is set to announce its Q2'26 results on July 16, after the market closes. The earnings are expected to be disclosed at 7:30 AM ET (11:30 AM UTC).
For Q2'26, revenue estimate is 12.52 billion USD with EPS (earnings per share) anticipated at 1.28 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported11.14 B11.37 B11.46 B11.16 B— | Revenue Estimate11.09 B11.39 B11.80 B11.00 B12.52 B | Revenue Surprise+0.45%-0.18%-2.89%+1.49% | EPS Reported1.261.301.501.15 | EPS Estimate1.261.301.501.141.28 | EPS Surprise+0.33%-0.21%+0.29%+0.47% |